Amanote Research
Register
Sign In
The HDAC Inhibitor LBH589 (Panobinostat) Is an Inhibitory Modulator of Aromatase Gene Expression
Proceedings of the National Academy of Sciences of the United States of America
- United States
doi 10.1073/pnas.1000917107
Full Text
Open PDF
Abstract
Available in
full text
Categories
Multidisciplinary
Date
June 1, 2010
Authors
S. Chen
J. Ye
I. Kijima
D. Evans
Publisher
Proceedings of the National Academy of Sciences
Related search
The HDAC Inhibitor LBH589 Enhances the Antimyeloma Effects of the IGF-1RTK Inhibitor Picropodophyllin
Clinical Cancer Research
Cancer Research
Oncology
An HDAC Inhibitor Increases AcMNPV Gene Expression in Mammalian Cells
Archives of Virology
Medicine
Virology
Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells
PLoS ONE
Multidisciplinary
HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2 + Tumors
Cancer Research
Cancer Research
Oncology
Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients
Clinical Breast Cancer
Cancer Research
Oncology
Sequential Changes in Gene Expression Profiles in Breast Cancers During Treatment With the Aromatase Inhibitor, Letrozole
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Rapid Recovery From Panobinostat (LBH589)-induced Thrombocytopenia in Mice Involves a Rebound Effect of Bone Marrow Megakaryocytes
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Design and Synthesis of a Novel Photochromic HDAC Inhibitor and Its Photo Reversible Inhibitory Effect
Biophysical Journal
Biophysics
Nuclear Factor-κB Is an Important Modulator of the Altered Gene Expression Profile and Malignant Phenotype in Squamous Cell Carcinoma
Cancer Research
Cancer Research
Oncology